User:Jason Hill

JOB HISTORY Chief Scientific Officer. 2011-Present. Cistrogene. Tinley Park, IL. Director, Strategic Business and Operations, Oncology. 2010 – Present. Quintiles. Westmont, IL. Associate Director, External Science Affairs. 2008 to 2010. TMD – A Quintiles Central Laboratory. Westmont, IL. Director, Molecular Biology. 2005 to 2008. Targeted Molecular Diagnostics, LLC (TMD). Westmont, IL. Senior Molecular Biologist. 2004 to 2005. Targeted Molecular Diagnostics, LLC (TMD). Westmont, IL. Postdoctoral Fellow. 2004. Cleveland Clinic Foundation. Cleveland, OH. Research Associate I. 1997 to 1998. Clontech. Palo Alto, CA.

EDUCATION Ph.D. Molecular Genetics. 2004. University of Illinois at Chicago. Chicago, IL. M.S. Biochemistry and Molecular Biology. Thomas Jefferson University. Philadelphia, PA. B.S. Biology. University of Scranton. Scranton, PA.

PUBLICATIONS (2004 – Present) Coughlin, C. M., Johnston, D. S., Strahs, A., Burczynski, M. E., Bacus, S., Hill, J., Feingold, J. M., Zacharchuk, C. and Berkenblit, A. (2010). Breast Cancer Res Treat 124, 1–11. Vaziri SA, Grabowski DR, Hill J, Rybicki LR, Burk R, Bukowski RM, Ganapathi MK, Ganapathi R. (2009). Anticancer Res 29, 2961-2969. Spector, N. L., Yarden, Y., Smith, B., Lyass, L., Trusk, P., Pry, K., Hill, J. E., Xia, W., Seger, R., and Bacus, S. S. (2007). Proc Natl Acad Sci U S A 104, 10607-10612. Xia, W., Bacus, S., Hegde, P., Husain, I., Strum, J., Liu, L., Paulazzo, G., Lyass, L., Trusk, P., Hill, J., et al. (2006). Proc Natl Acad Sci U S A 103, 7795-7800. Chikamori, K., Hill, J. E., Grabowski, D. R., Zarkhin, E., Grozav, A. G., Vaziri, S. A., Wang, J., Gudkov, A. V., Rybicki, L. R., Bukowski, R. M., et al. (2006). Leukemia 20, 1809-1818. Burdelya, L. G., Komarova, E. A., Hill, J. E., Browder, T., Tararova, N. D., Mavrakis, L., Dicorleto, P. E., Folkman, J., and Gudkov, A. V. (2006). Cancer Res 66, 9356-9361. Vaziri, S. A., Hill, J., Chikamori, K., Grabowski, D. R., Takigawa, N., Chawla-Sarkar, M., Rybicki, L. R., Gudkov, A. V., Mekhail, T., Bukowski, R. M., et al. (2005). Mol Cancer Ther 4, 1880-1890. Marques, J. T., Rebouillat, D., Ramana, C. V., Murakami, J., Hill, J. E., Gudkov, A., Silverman, R. H., Stark, G. R., and Williams, B. R. (2005). J Virol 79, 11105-11114. Gurova, K. V.*, Hill, J. E.*, Guo, C., Prokvolit, A., Burdelya, L. G., Samoylova, E., Khodyakova, A. V., Ganapathi, R., Ganapathi, M., Tararova, N. D., et al. (2005). Proc Natl Acad Sci U S A 102, 17448–17453. * These two authors contributed equally.

PATENTS • Bacus, Sarah, S. and Hill, Jason E. “Methods and materials for predicting responsiveness to treatment with dual tyrosine kinase inhibitor.” U.S. Patent 7,862,995. January 4, 2011.

PATENT APPLICATIONS • Bacus, Sarah S., Hill, Jason E., Yarden, Yosef and Kochupurakkal, Bose S. “Bivalent ErbB Ligand Binding Molecules And Methods For Their Preparation And Use.” Pub No. 20090318346 A1. • Hill, Jason E. “Broad Spectrum ErbB Ligand Binding Molecules And Methods For Preparing And Using Them.” Pub No. PCT/US2010/043533.